Corporate Bitcoin Treasuries Explained: Why Public Companies Hold Bitcoin
Public companies hold bitcoin because they view it as a scarce, dollar-denominated reserve asset that can diversify treasury holdings, preserve purchasing power against inflation, attract investors, and provide exposure...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Public companies hold bitcoin because they view it as a scarce, dollar-denominated reserve asset that can diversify treasury holdings, preserve purchasing power against inflation, attract investors, and provide exposure to the digital asset economy. The model was pioneered by Strategy (formerly MicroStrategy) and has since been adopted by Tesla, Block, Metaplanet, and a range of […]
Why this matters
Bitcoin is showing up inside the Institutional Adoption theme, so this story is worth tracking for follow-through rather than treating it as a one-off headline.
Original source
Read on The BlockRelated market context
Why 110 corporate blockchains are headed for a massive shakeout – and Coinbase’s secret plan to absorb them
Corporate blockchains are multiplying, but Coinbase CEO Brian Armstrong expects the boom to end in consolidation rather than coexi...
Lite Strategy Funds $5.4M Buyback With Litecoin Sales And Covered Calls
Lite Strategy has repurchased 4.9 million shares for $5.4 million, using Litecoin treasury activity and covered-call premiums to f...
One public crypto firm just staked its way to breaking even, but a $50M paper loss and 66% dilution threat tell a darker story
Stablecoin Development Corporation, a public company built around holding and staking Sky Protocol's SKY governance token, reporte...
3iQ Corp Named Institutional Manager of Bhutan’s Bitcoin Reserves
In the latest Bitcoin news, Gelephu Mindfulness City, Bhutan’s southern special administrative region, has named Toronto-based 3iQ...
Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of financing tied to the RA...
How thin weekend Bitcoin liquidity turns minor geopolitical news into massive Monday price gaps for ETF holders
An investor who owns Bitcoin through a brokerage account can finish work on Friday, check the closing price of a spot ETF, and ass...